Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China; Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
J Arthroplasty. 2020 Nov;35(11):3223-3229. doi: 10.1016/j.arth.2020.06.023. Epub 2020 Jun 17.
The optimal dose regimen of dexamethasone in total hip arthroplasty (THA) is unclear. This study was conducted to compare the effects among 1-dose, 2-dose, and 3-dose dexamethasone in THA.
One hundred fifty patients were randomized to receive a single preoperative dose of 10-mg dexamethasone (group A, 50 patients), or another dose of 10-mg dexamethasone 24 hours later (group B, 50 patients), or another 2 doses of 10-mg dexamethasone 24 and 48 hours later (group C, 50 patients). The primary outcome was postoperative pain level. The use of analgesic and antiemetic rescue; incidence of postoperative nausea and vomiting; C-reactive protein and interleukin-6 levels; range of motion; and complications were also compared.
The dynamic pain scores were lower for groups B and C compared to group A on postoperative days 2 and 3. Such difference was also detected between groups B and C on postoperative day 3. C-reactive protein and interleukin-6 levels were lower in groups B and C than in group A at 48 and 72 hours postoperatively. Such difference was also observed between groups B and C at 72 hours postoperatively. Patients in groups B and C had reduced rescue analgesic use, and improved range of motion compared to patients in group A. There were no differences among 3 groups regarding the rescue antiemetic use, postoperative nausea and vomiting occurrence, and complications.
Additional administrations of dexamethasone after THA could provide sustained pain relief and inflammatory control. Besides, the 3-dose regimen was more effective than the 2-dose regimen in terms of the analgesic and anti-inflammatory effects.
I.
在全髋关节置换术(THA)中,地塞米松的最佳剂量方案尚不清楚。本研究旨在比较单次、两次和三次地塞米松给药在 THA 中的效果。
将 150 名患者随机分为三组,分别在术前接受单次 10mg 地塞米松(A 组,50 例)、24 小时后再次给予 10mg 地塞米松(B 组,50 例)或 24 小时和 48 小时后再次给予 2 次 10mg 地塞米松(C 组,50 例)。主要结局为术后疼痛程度。还比较了镇痛和止吐补救药物的使用、术后恶心和呕吐的发生率、C 反应蛋白和白细胞介素 6 水平、活动范围以及并发症。
与 A 组相比,B 组和 C 组在术后第 2 天和第 3 天的动态疼痛评分较低,C 组在术后第 3 天的差异也有统计学意义。B 组和 C 组在术后 48 小时和 72 小时的 C 反应蛋白和白细胞介素 6 水平低于 A 组,B 组和 C 组在术后 72 小时的差异也有统计学意义。与 A 组相比,B 组和 C 组的患者需要较少的补救镇痛药物,活动范围更大。三组患者在止吐补救药物使用、术后恶心和呕吐发生率和并发症方面无差异。
THA 后多次给予地塞米松可提供持续的疼痛缓解和炎症控制。此外,3 剂量方案在镇痛和抗炎效果方面优于 2 剂量方案。
I 级。